Reveal Lasers LLC Introduces Nirvana: Diode Laser Technology for Laser Hair Removal
LAS VEGAS, NV / ACCESSWIRE / May 9, 2024 / Reveal Lasers is happy to announce the launch of Nirvana,...
Day: May 9, 2024
LENSAR Reports First Quarter 2024 Results and Provides Business Update
Total Revenue increased 28% and Procedure volume increased 25% over the first quarter of 2023 Increased ALLY® Adaptive Cataract Treatment...
Sonendo, Inc. Reports First Quarter 2024 Financial Results and Announces Strategic Reset Priorities
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (OTCQX: SONX) (“Sonendo”), a leading dental technology company and developer of the GentleWave® System, today...
Outset Medical Reports First Quarter 2024 Financial Results
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology...
Establishment Labs Reports First Quarter 2024 Financial Results
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,...
TruBridge and Multiview Announce Preferred Partnership Making Enhanced Financial Management Solutions Available to TruBridge Clients
MOBILE, Ala.--(BUSINESS WIRE)--TruBridge, Inc. (NASDAQ: TBRG), a healthcare solutions company, and Multiview Financial Software (Multiview) announced a newly formed strategic...
CBD of Denver Inc. Announces Filing of Q1 Quarterly Disclosure and Financials
Denver, Colorado--(Newsfile Corp. - May 9, 2024) - CBD of Denver, Inc. (OTC Pink: CBDD) is pleased to announce the...
CBD of Denver Inc. Announces Filing of Q1 Quarterly Disclosure and Financials
Denver, Colorado--(Newsfile Corp. - May 9, 2024) - CBD of Denver, Inc. (OTC Pink: CBDD) is pleased to announce the...
FendX Technologies Announces Closing of Non-Brokered Private Placement
Oakville, Ontario--(Newsfile Corp. - May 8, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or...
FendX Technologies Announces Closing of Non-Brokered Private Placement
Oakville, Ontario--(Newsfile Corp. - May 8, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or...
Glow Announces Cease Trade Order
Toronto, Ontario--(Newsfile Corp. - May 8, 2024) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) ("Glow" or the "Company") announces...
Glow Announces Cease Trade Order
Toronto, Ontario--(Newsfile Corp. - May 8, 2024) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) ("Glow" or the "Company") announces...
Neural Therapeutics Receives Conditional Approval to Listing on the CSE and Announces Concurrent Financing
Toronto, Ontario--(Newsfile Corp. - May 8, 2024) - Neural Therapeutics Inc. ("Neural" or the "Company"), an ethnobotanical drug discovery company...
Neural Therapeutics Receives Conditional Approval to Listing on the CSE and Announces Concurrent Financing
Toronto, Ontario--(Newsfile Corp. - May 8, 2024) - Neural Therapeutics Inc. ("Neural" or the "Company"), an ethnobotanical drug discovery company...
Welter Healthcare Partners Earns Prestigious NCQA Credentials Verification Organization (CVO) Certification
Achieving this honor places Welter Healthcare Partners in an elite group of six companies that have achieved the coveted URAC...
Welter Healthcare Partners Earns Prestigious NCQA Credentials Verification Organization (CVO) Certification
Achieving this honor places Welter Healthcare Partners in an elite group of six companies that have achieved the coveted URAC...
Jaguar Health Announces Submission of Clinical Trial Applications for Crofelemer for the Rare Disease Indications Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome (SBS) in Europe
Jaguar's novel plant-based prescription drug crofelemer has been granted Orphan Drug Designation by the FDA and the European Medicines Agency...
Jaguar Health Announces Submission of Clinical Trial Applications for Crofelemer for the Rare Disease Indications Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome (SBS) in Europe
Jaguar's novel plant-based prescription drug crofelemer has been granted Orphan Drug Designation by the FDA and the European Medicines Agency...
Gilead’s FOCUS Program Helps Zero In on Early HIV Detection
NORTHAMPTON, MA / ACCESSWIRE / May 9, 2024 / A 22-year-old college student who didn't feel well was treated at...
Gilead’s FOCUS Program Helps Zero In on Early HIV Detection
NORTHAMPTON, MA / ACCESSWIRE / May 9, 2024 / A 22-year-old college student who didn't feel well was treated at...